I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Global Competitor Market Shares
Arbovirus Testing Competitor Market Share Scenario Worldwide:
(in %): 2019 & 2025
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Arbovirus Testing
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027

Table 2: World Historic Review for Arbovirus Testing by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019

Table 3: World 15-Year Perspective for Arbovirus Testing by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets for Years 2012, 2020 & 2027

Table 4: World Current & Future Analysis for ELISA-based Tests
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027

Table 5: World Historic Review for ELISA-based Tests by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019

Table 6: World 15-Year Perspective for ELISA-based Tests by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 7: World Current & Future Analysis for RT-PCR based Tests
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027

Table 8: World Historic Review for RT-PCR based Tests by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019

Table 9: World 15-Year Perspective for RT-PCR based Tests by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 10: World Current & Future Analysis for Hospitals by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027

Table 11: World Historic Review for Hospitals by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019

Table 12: World 15-Year Perspective for Hospitals by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027

Table 13: World Current & Future Analysis for Public Health
Laboratory by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027

Table 14: World Historic Review for Public Health Laboratory by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019

Table 15: World 15-Year Perspective for Public Health
Laboratory by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2020 &
2027

Table 16: World Current & Future Analysis for Diagnostic
Centers by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027

Table 17: World Historic Review for Diagnostic Centers by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019

Table 18: World 15-Year Perspective for Diagnostic Centers by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 19: World Current & Future Analysis for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027

Table 20: World Historic Review for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019

Table 21: World 15-Year Perspective for Other End-Uses by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES
Market Facts & Figures
US Arbovirus Testing Market Share (in %) by Company: 2019 & 2025
Market Analytics
Table 22: USA Current & Future Analysis for Arbovirus Testing
by Test Type - ELISA-based Tests and RT-PCR based Tests -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027

Table 23: USA Historic Review for Arbovirus Testing by Test
Type - ELISA-based Tests and RT-PCR based Tests Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019

Table 24: USA 15-Year Perspective for Arbovirus Testing by Test
Type - Percentage Breakdown of Value Sales for ELISA-based
Tests and RT-PCR based Tests for the Years 2012, 2020 & 2027

Table 25: USA Current & Future Analysis for Arbovirus Testing
by End-Use - Hospitals, Public Health Laboratory, Diagnostic
Centers and Other End-Uses - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027

Table 26: USA Historic Review for Arbovirus Testing by End-Use -
Hospitals, Public Health Laboratory, Diagnostic Centers and
Other End-Uses Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019

Table 27: USA 15-Year Perspective for Arbovirus Testing by
End-Use - Percentage Breakdown of Value Sales for Hospitals,
Public Health Laboratory, Diagnostic Centers and Other End-Uses
for the Years 2012, 2020 & 2027

CANADA
Table 28: Canada Current & Future Analysis for Arbovirus
Testing by Test Type - ELISA-based Tests and RT-PCR based Tests -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027

Table 29: Canada Historic Review for Arbovirus Testing by Test
Type - ELISA-based Tests and RT-PCR based Tests Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019

Table 30: Canada 15-Year Perspective for Arbovirus Testing by
Test Type - Percentage Breakdown of Value Sales for ELISA-based
Tests and RT-PCR based Tests for the Years 2012, 2020 & 2027

Table 31: Canada Current & Future Analysis for Arbovirus
Testing by End-Use - Hospitals, Public Health Laboratory,
Diagnostic Centers and Other End-Uses - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027

Table 32: Canada Historic Review for Arbovirus Testing by
End-Use - Hospitals, Public Health Laboratory, Diagnostic
Centers and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019

Table 33: Canada 15-Year Perspective for Arbovirus Testing by
End-Use - Percentage Breakdown of Value Sales for Hospitals,
Public Health Laboratory, Diagnostic Centers and Other End-Uses
for the Years 2012, 2020 & 2027

JAPAN
Table 34: Japan Current & Future Analysis for Arbovirus Testing
by Test Type - ELISA-based Tests and RT-PCR based Tests -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027

Table 35: Japan Historic Review for Arbovirus Testing by Test
Type - ELISA-based Tests and RT-PCR based Tests Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019

Table 36: Japan 15-Year Perspective for Arbovirus Testing by
Test Type - Percentage Breakdown of Value Sales for ELISA-based
Tests and RT-PCR based Tests for the Years 2012, 2020 & 2027

Table 37: Japan Current & Future Analysis for Arbovirus Testing
by End-Use - Hospitals, Public Health Laboratory, Diagnostic
Centers and Other End-Uses - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027

Table 38: Japan Historic Review for Arbovirus Testing by
End-Use - Hospitals, Public Health Laboratory, Diagnostic
Centers and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019

Table 39: Japan 15-Year Perspective for Arbovirus Testing by
End-Use - Percentage Breakdown of Value Sales for Hospitals,
Public Health Laboratory, Diagnostic Centers and Other End-Uses
for the Years 2012, 2020 & 2027

CHINA
Table 40: China Current & Future Analysis for Arbovirus Testing
by Test Type - ELISA-based Tests and RT-PCR based Tests -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027

Table 41: China Historic Review for Arbovirus Testing by Test
Type - ELISA-based Tests and RT-PCR based Tests Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019

Table 42: China 15-Year Perspective for Arbovirus Testing by
Test Type - Percentage Breakdown of Value Sales for ELISA-based
Tests and RT-PCR based Tests for the Years 2012, 2020 & 2027

Table 43: China Current & Future Analysis for Arbovirus Testing
by End-Use - Hospitals, Public Health Laboratory, Diagnostic
Centers and Other End-Uses - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027

Table 44: China Historic Review for Arbovirus Testing by
End-Use - Hospitals, Public Health Laboratory, Diagnostic
Centers and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019

Table 45: China 15-Year Perspective for Arbovirus Testing by
End-Use - Percentage Breakdown of Value Sales for Hospitals,
Public Health Laboratory, Diagnostic Centers and Other End-Uses
for the Years 2012, 2020 & 2027

EUROPE
Market Facts & Figures
European Arbovirus Testing Market: Competitor Market Share
Scenario (in %) for 2019 & 2025
Market Analytics
Table 46: Europe Current & Future Analysis for Arbovirus
Testing by Geographic Region - France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027

Table 47: Europe Historic Review for Arbovirus Testing by
Geographic Region - France, Germany, Italy, UK, Spain, Russia
and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019

Table 48: Europe 15-Year Perspective for Arbovirus Testing by
Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets for Years 2012, 2020 & 2027

Table 49: Europe Current & Future Analysis for Arbovirus
Testing by Test Type - ELISA-based Tests and RT-PCR based Tests -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027

Table 50: Europe Historic Review for Arbovirus Testing by Test
Type - ELISA-based Tests and RT-PCR based Tests Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019

Table 51: Europe 15-Year Perspective for Arbovirus Testing by
Test Type - Percentage Breakdown of Value Sales for ELISA-based
Tests and RT-PCR based Tests for the Years 2012, 2020 & 2027

Table 52: Europe Current & Future Analysis for Arbovirus
Testing by End-Use - Hospitals, Public Health Laboratory,
Diagnostic Centers and Other End-Uses - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027

Table 53: Europe Historic Review for Arbovirus Testing by
End-Use - Hospitals, Public Health Laboratory, Diagnostic
Centers and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019

Table 54: Europe 15-Year Perspective for Arbovirus Testing by
End-Use - Percentage Breakdown of Value Sales for Hospitals,
Public Health Laboratory, Diagnostic Centers and Other End-Uses
for the Years 2012, 2020 & 2027

FRANCE
Table 55: France Current & Future Analysis for Arbovirus
Testing by Test Type - ELISA-based Tests and RT-PCR based Tests -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027

Table 56: France Historic Review for Arbovirus Testing by Test
Type - ELISA-based Tests and RT-PCR based Tests Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019

Table 57: France 15-Year Perspective for Arbovirus Testing by
Test Type - Percentage Breakdown of Value Sales for ELISA-based
Tests and RT-PCR based Tests for the Years 2012, 2020 & 2027

Table 58: France Current & Future Analysis for Arbovirus
Testing by End-Use - Hospitals, Public Health Laboratory,
Diagnostic Centers and Other End-Uses - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027

Table 59: France Historic Review for Arbovirus Testing by
End-Use - Hospitals, Public Health Laboratory, Diagnostic
Centers and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019

Table 60: France 15-Year Perspective for Arbovirus Testing by
End-Use - Percentage Breakdown of Value Sales for Hospitals,
Public Health Laboratory, Diagnostic Centers and Other End-Uses
for the Years 2012, 2020 & 2027

GERMANY
Table 61: Germany Current & Future Analysis for Arbovirus
Testing by Test Type - ELISA-based Tests and RT-PCR based Tests -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027

Table 62: Germany Historic Review for Arbovirus Testing by Test
Type - ELISA-based Tests and RT-PCR based Tests Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019

Table 63: Germany 15-Year Perspective for Arbovirus Testing by
Test Type - Percentage Breakdown of Value Sales for ELISA-based
Tests and RT-PCR based Tests for the Years 2012, 2020 & 2027

Table 64: Germany Current & Future Analysis for Arbovirus
Testing by End-Use - Hospitals, Public Health Laboratory,
Diagnostic Centers and Other End-Uses - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027

Table 65: Germany Historic Review for Arbovirus Testing by
End-Use - Hospitals, Public Health Laboratory, Diagnostic
Centers and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019

Table 66: Germany 15-Year Perspective for Arbovirus Testing by
End-Use - Percentage Breakdown of Value Sales for Hospitals,
Public Health Laboratory, Diagnostic Centers and Other End-Uses
for the Years 2012, 2020 & 2027

ITALY
Table 67: Italy Current & Future Analysis for Arbovirus Testing
by Test Type - ELISA-based Tests and RT-PCR based Tests -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027

Table 68: Italy Historic Review for Arbovirus Testing by Test
Type - ELISA-based Tests and RT-PCR based Tests Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019

Table 69: Italy 15-Year Perspective for Arbovirus Testing by
Test Type - Percentage Breakdown of Value Sales for ELISA-based
Tests and RT-PCR based Tests for the Years 2012, 2020 & 2027

Table 70: Italy Current & Future Analysis for Arbovirus Testing
by End-Use - Hospitals, Public Health Laboratory, Diagnostic
Centers and Other End-Uses - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027

Table 71: Italy Historic Review for Arbovirus Testing by
End-Use - Hospitals, Public Health Laboratory, Diagnostic
Centers and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019

Table 72: Italy 15-Year Perspective for Arbovirus Testing by
End-Use - Percentage Breakdown of Value Sales for Hospitals,
Public Health Laboratory, Diagnostic Centers and Other End-Uses
for the Years 2012, 2020 & 2027

UNITED KINGDOM
Table 73: UK Current & Future Analysis for Arbovirus Testing by
Test Type - ELISA-based Tests and RT-PCR based Tests -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027

Table 74: UK Historic Review for Arbovirus Testing by Test Type -
ELISA-based Tests and RT-PCR based Tests Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019

Table 75: UK 15-Year Perspective for Arbovirus Testing by Test
Type - Percentage Breakdown of Value Sales for ELISA-based
Tests and RT-PCR based Tests for the Years 2012, 2020 & 2027

Table 76: UK Current & Future Analysis for Arbovirus Testing by
End-Use - Hospitals, Public Health Laboratory, Diagnostic
Centers and Other End-Uses - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027

Table 77: UK Historic Review for Arbovirus Testing by End-Use -
Hospitals, Public Health Laboratory, Diagnostic Centers and
Other End-Uses Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019

Table 78: UK 15-Year Perspective for Arbovirus Testing by
End-Use - Percentage Breakdown of Value Sales for Hospitals,
Public Health Laboratory, Diagnostic Centers and Other End-Uses
for the Years 2012, 2020 & 2027

SPAIN
Table 79: Spain Current & Future Analysis for Arbovirus Testing
by Test Type - ELISA-based Tests and RT-PCR based Tests -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027

Table 80: Spain Historic Review for Arbovirus Testing by Test
Type - ELISA-based Tests and RT-PCR based Tests Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019

Table 81: Spain 15-Year Perspective for Arbovirus Testing by
Test Type - Percentage Breakdown of Value Sales for ELISA-based
Tests and RT-PCR based Tests for the Years 2012, 2020 & 2027

Table 82: Spain Current & Future Analysis for Arbovirus Testing
by End-Use - Hospitals, Public Health Laboratory, Diagnostic
Centers and Other End-Uses - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027

Table 83: Spain Historic Review for Arbovirus Testing by
End-Use - Hospitals, Public Health Laboratory, Diagnostic
Centers and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019

Table 84: Spain 15-Year Perspective for Arbovirus Testing by
End-Use - Percentage Breakdown of Value Sales for Hospitals,
Public Health Laboratory, Diagnostic Centers and Other End-Uses
for the Years 2012, 2020 & 2027

RUSSIA
Table 85: Russia Current & Future Analysis for Arbovirus
Testing by Test Type - ELISA-based Tests and RT-PCR based Tests -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027

Table 86: Russia Historic Review for Arbovirus Testing by Test
Type - ELISA-based Tests and RT-PCR based Tests Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019

Table 87: Russia 15-Year Perspective for Arbovirus Testing by
Test Type - Percentage Breakdown of Value Sales for ELISA-based
Tests and RT-PCR based Tests for the Years 2012, 2020 & 2027

Table 88: Russia Current & Future Analysis for Arbovirus
Testing by End-Use - Hospitals, Public Health Laboratory,
Diagnostic Centers and Other End-Uses - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027

Table 89: Russia Historic Review for Arbovirus Testing by
End-Use - Hospitals, Public Health Laboratory, Diagnostic
Centers and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019

Table 90: Russia 15-Year Perspective for Arbovirus Testing by
End-Use - Percentage Breakdown of Value Sales for Hospitals,
Public Health Laboratory, Diagnostic Centers and Other End-Uses
for the Years 2012, 2020 & 2027

REST OF EUROPE
Table 91: Rest of Europe Current & Future Analysis for
Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR
based Tests - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027

Table 92: Rest of Europe Historic Review for Arbovirus Testing
by Test Type - ELISA-based Tests and RT-PCR based Tests Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019

Table 93: Rest of Europe 15-Year Perspective for Arbovirus
Testing by Test Type - Percentage Breakdown of Value Sales for
ELISA-based Tests and RT-PCR based Tests for the Years 2012,
2020 & 2027

Table 94: Rest of Europe Current & Future Analysis for
Arbovirus Testing by End-Use - Hospitals, Public Health
Laboratory, Diagnostic Centers and Other End-Uses - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027

Table 95: Rest of Europe Historic Review for Arbovirus Testing
by End-Use - Hospitals, Public Health Laboratory, Diagnostic
Centers and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019

Table 96: Rest of Europe 15-Year Perspective for Arbovirus
Testing by End-Use - Percentage Breakdown of Value Sales for
Hospitals, Public Health Laboratory, Diagnostic Centers and
Other End-Uses for the Years 2012, 2020 & 2027

ASIA-PACIFIC
Table 97: Asia-Pacific Current & Future Analysis for Arbovirus
Testing by Geographic Region - Australia, India, South Korea
and Rest of Asia-Pacific Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2020 through 2027

Table 98: Asia-Pacific Historic Review for Arbovirus Testing by
Geographic Region - Australia, India, South Korea and Rest of
Asia-Pacific Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019

Table 99: Asia-Pacific 15-Year Perspective for Arbovirus
Testing by Geographic Region - Percentage Breakdown of Value
Sales for Australia, India, South Korea and Rest of
Asia-Pacific Markets for Years 2012, 2020 & 2027

Table 100: Asia-Pacific Current & Future Analysis for Arbovirus
Testing by Test Type - ELISA-based Tests and RT-PCR based Tests -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027

Table 101: Asia-Pacific Historic Review for Arbovirus Testing
by Test Type - ELISA-based Tests and RT-PCR based Tests Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019

Table 102: Asia-Pacific 15-Year Perspective for Arbovirus
Testing by Test Type - Percentage Breakdown of Value Sales for
ELISA-based Tests and RT-PCR based Tests for the Years 2012,
2020 & 2027

Table 103: Asia-Pacific Current & Future Analysis for Arbovirus
Testing by End-Use - Hospitals, Public Health Laboratory,
Diagnostic Centers and Other End-Uses - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027

Table 104: Asia-Pacific Historic Review for Arbovirus Testing
by End-Use - Hospitals, Public Health Laboratory, Diagnostic
Centers and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019

Table 105: Asia-Pacific 15-Year Perspective for Arbovirus
Testing by End-Use - Percentage Breakdown of Value Sales for
Hospitals, Public Health Laboratory, Diagnostic Centers and
Other End-Uses for the Years 2012, 2020 & 2027

AUSTRALIA
Table 106: Australia Current & Future Analysis for Arbovirus
Testing by Test Type - ELISA-based Tests and RT-PCR based Tests -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027

Table 107: Australia Historic Review for Arbovirus Testing by
Test Type - ELISA-based Tests and RT-PCR based Tests Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019

Table 108: Australia 15-Year Perspective for Arbovirus Testing
by Test Type - Percentage Breakdown of Value Sales for
ELISA-based Tests and RT-PCR based Tests for the Years 2012,
2020 & 2027

Table 109: Australia Current & Future Analysis for Arbovirus
Testing by End-Use - Hospitals, Public Health Laboratory,
Diagnostic Centers and Other End-Uses - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027

Table 110: Australia Historic Review for Arbovirus Testing by
End-Use - Hospitals, Public Health Laboratory, Diagnostic
Centers and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019

Table 111: Australia 15-Year Perspective for Arbovirus Testing
by End-Use - Percentage Breakdown of Value Sales for Hospitals,
Public Health Laboratory, Diagnostic Centers and Other End-Uses
for the Years 2012, 2020 & 2027

INDIA
Table 112: India Current & Future Analysis for Arbovirus
Testing by Test Type - ELISA-based Tests and RT-PCR based Tests -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027

Table 113: India Historic Review for Arbovirus Testing by Test
Type - ELISA-based Tests and RT-PCR based Tests Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019

Table 114: India 15-Year Perspective for Arbovirus Testing by
Test Type - Percentage Breakdown of Value Sales for ELISA-based
Tests and RT-PCR based Tests for the Years 2012, 2020 & 2027

Table 115: India Current & Future Analysis for Arbovirus
Testing by End-Use - Hospitals, Public Health Laboratory,
Diagnostic Centers and Other End-Uses - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027

Table 116: India Historic Review for Arbovirus Testing by
End-Use - Hospitals, Public Health Laboratory, Diagnostic
Centers and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019

Table 117: India 15-Year Perspective for Arbovirus Testing by
End-Use - Percentage Breakdown of Value Sales for Hospitals,
Public Health Laboratory, Diagnostic Centers and Other End-Uses
for the Years 2012, 2020 & 2027

SOUTH KOREA
Table 118: South Korea Current & Future Analysis for Arbovirus
Testing by Test Type - ELISA-based Tests and RT-PCR based Tests -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027

Table 119: South Korea Historic Review for Arbovirus Testing by
Test Type - ELISA-based Tests and RT-PCR based Tests Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019

Table 120: South Korea 15-Year Perspective for Arbovirus
Testing by Test Type - Percentage Breakdown of Value Sales for
ELISA-based Tests and RT-PCR based Tests for the Years 2012,
2020 & 2027

Table 121: South Korea Current & Future Analysis for Arbovirus
Testing by End-Use - Hospitals, Public Health Laboratory,
Diagnostic Centers and Other End-Uses - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027

Table 122: South Korea Historic Review for Arbovirus Testing by
End-Use - Hospitals, Public Health Laboratory, Diagnostic
Centers and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019

Table 123: South Korea 15-Year Perspective for Arbovirus
Testing by End-Use - Percentage Breakdown of Value Sales for
Hospitals, Public Health Laboratory, Diagnostic Centers and
Other End-Uses for the Years 2012, 2020 & 2027

REST OF ASIA-PACIFIC
Table 124: Rest of Asia-Pacific Current & Future Analysis for
Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR
based Tests - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027

Table 125: Rest of Asia-Pacific Historic Review for Arbovirus
Testing by Test Type - ELISA-based Tests and RT-PCR based Tests
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019

Table 126: Rest of Asia-Pacific 15-Year Perspective for
Arbovirus Testing by Test Type - Percentage Breakdown of Value
Sales for ELISA-based Tests and RT-PCR based Tests for the
Years 2012, 2020 & 2027

Table 127: Rest of Asia-Pacific Current & Future Analysis for
Arbovirus Testing by End-Use - Hospitals, Public Health
Laboratory, Diagnostic Centers and Other End-Uses - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027

Table 128: Rest of Asia-Pacific Historic Review for Arbovirus
Testing by End-Use - Hospitals, Public Health Laboratory,
Diagnostic Centers and Other End-Uses Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019

Table 129: Rest of Asia-Pacific 15-Year Perspective for
Arbovirus Testing by End-Use - Percentage Breakdown of Value
Sales for Hospitals, Public Health Laboratory, Diagnostic
Centers and Other End-Uses for the Years 2012, 2020 & 2027

LATIN AMERICA
Table 130: Latin America Current & Future Analysis for
Arbovirus Testing by Geographic Region - Argentina, Brazil,
Mexico and Rest of Latin America Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027

Table 131: Latin America Historic Review for Arbovirus Testing
by Geographic Region - Argentina, Brazil, Mexico and Rest of
Latin America Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019

Table 132: Latin America 15-Year Perspective for Arbovirus
Testing by Geographic Region - Percentage Breakdown of Value
Sales for Argentina, Brazil, Mexico and Rest of Latin America
Markets for Years 2012, 2020 & 2027

Table 133: Latin America Current & Future Analysis for
Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR
based Tests - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027

Table 134: Latin America Historic Review for Arbovirus Testing
by Test Type - ELISA-based Tests and RT-PCR based Tests Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019

Table 135: Latin America 15-Year Perspective for Arbovirus
Testing by Test Type - Percentage Breakdown of Value Sales for
ELISA-based Tests and RT-PCR based Tests for the Years 2012,
2020 & 2027

Table 136: Latin America Current & Future Analysis for
Arbovirus Testing by End-Use - Hospitals, Public Health
Laboratory, Diagnostic Centers and Other End-Uses - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027

Table 137: Latin America Historic Review for Arbovirus Testing
by End-Use - Hospitals, Public Health Laboratory, Diagnostic
Centers and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019

Table 138: Latin America 15-Year Perspective for Arbovirus

Please contact our Customer Support Center to get the complete Table of Contents